Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00043394
Status:
COMPLETED
Last Update Posted:
2009-03-12
First Post:
2002-08-08
Brief Title:
CPG 7909 Plus Herceptin In Patients With Metastatic Breast Cancer
Sponsor:
Pfizer
Organization:
Pfizer
Organization Data
Organization:
Pfizer
Class:
INDUSTRY
Study ID:
C015
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Pfizer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Director Clinical Trial Disclosure Group
Old Organization:
Pfizer Inc